Clinical Trial

a Prospective Randomised Study Evaluating the Efficacy of Intranasal Midazolam and Dexmedetomidine as a Sedative Agent in Management of Mandible Fracture

Enrolling by Invitation Early Phase 1
View on ClinicalTrials.gov →
Summary
COMPARISON OF THE EFFICACY OF INTRANASAL MIDAZOLAM AND DEXMEDETOMIDINE AS A SEDATIVE AGENT IN SURGICAL MANAGEMENT OF ISOLATED MANDIBLE FRACTURE- conducted on 32 subject to assess depth of sedation by using OAA/S and assess effect on bp and heart rate
Trial Details
NCT Number NCT07502651
Lead Sponsor Postgraduate Institute of Dental Sciences Rohtak
Conditions Sedation
Enrollment 32 participants
Start Date 2025-05-25
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-04-25 (estimated)
Updated on ClinicalTrials.gov 2026-03-31